Introduction to Braftovi (Encorafenib) 75mg
Braftovi (Encorafenib) 75mg is a powerful prescription medicine used in the treatment of certain cancers, particularly melanoma and some colorectal cancers with specific BRAF mutations. This medicine belongs to a specialized group of targeted oncology drugs that work by blocking abnormal cancer growth signals inside tumor cells.
Braftovi (Encorafenib) 75mg is classified under Prescription Medicines, Oncology Medicines, Anticancer Drugs, and Oral Targeted Cancer Therapies. It contains Encorafenib, which works by inhibiting mutated BRAF proteins involved in cancer cell growth and survival.
In some markets, Encoraf 75mg is available as a generic brand containing the same active ingredient Encorafenib, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.
What Is Braftovi (Encorafenib)?
Braftovi is the brand name for Encorafenib, an oral medication widely used for the treatment of certain BRAF mutation-positive cancers.
Encorafenib belongs to a class of medicines known as BRAF Inhibitors. These medicines help regulate abnormal cell signaling pathways while also inhibiting cancer growth.
Generic versions such as Encoraf 75mg contain the same active compound and may be used depending on physician recommendation and regional availability.
Drug Class and Mechanism of Action
Encorafenib is classified as a targeted anticancer and kinase inhibitor agent with strong antineoplastic properties.
How Encorafenib Works
It works in several ways:
Blocks mutated BRAF kinase activity involved in tumor growth
Interrupts cancer cell signaling pathways that promote survival
Helps slow the multiplication of abnormal cancer cells
Through these mechanisms, Encorafenib helps slow or stop the progression of certain cancers.
How Braftovi Works in the Body
Some cancer cells depend on abnormal BRAF signaling to survive and multiply. Braftovi helps disrupt this process by selectively targeting mutated BRAF proteins.
Key Actions of Encorafenib
Inhibiting BRAF-driven cancer cell growth
Reducing abnormal tumor signaling activity
Supporting targeted treatment in mutation-positive cancers
Some generic versions such as Encoraf deliver the same active compound, allowing similar mutation-targeted cancer treatment when prescribed appropriately.
Medical Uses of Braftovi (Encorafenib) 75mg
Braftovi 75mg is widely prescribed for several serious cancers associated with specific genetic mutations.
Braftovi for Melanoma
For patients with unresectable or metastatic melanoma with a BRAF V600 mutation, Braftovi is commonly used together with binimetinib.
Potential Benefits
Helps slow tumor progression
Improves progression-free survival in eligible patients
Provides mutation-targeted therapy for advanced melanoma
Generic alternatives like Encoraf 75mg may also be used under medical supervision when Encorafenib therapy is recommended.
Braftovi for Colorectal Cancer
Braftovi may also be used in certain patients with metastatic colorectal cancer carrying a BRAF V600E mutation, usually in combination with other medicines.
Treatment Benefits
Targets cancer growth related to BRAF mutation
May improve disease control in selected patients
Supports personalized cancer treatment strategies
Who Can Take Encoraf 75mg?
Because Encorafenib is a potent medicine, treatment should always be supervised by an experienced healthcare provider.
Eligibility Criteria
Patients may be prescribed Braftovi if they:
Have confirmed BRAF mutation-positive melanoma or colorectal cancer
Have been evaluated for targeted therapy suitability
Can undergo regular monitoring during treatment
Certain generic options such as Encoraf may also be considered depending on availability and physician decision.
Who Should Avoid Braftovi (Encorafenib) 75mg
Braftovi should NOT be used by:
Pregnant women or women planning pregnancy
Individuals with hypersensitivity to Encorafenib
Patients with certain severe liver problems unless monitored by a specialist
Braftovi (Encorafenib) 75mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
Braftovi 75mg taken as prescribed by the oncologist
Usually taken orally in combination with other anticancer medicines depending on indication
Capsules should be swallowed whole
Can be taken with or without food
Dosage Adjustments
Doctors may adjust the dose depending on:
Liver function
Treatment-related side effects
Individual response and combination therapy protocol
Side Effects of Braftovi 75mg
Like all cancer medicines, Braftovi may cause side effects.
Common Side Effects
Fatigue
Nausea
Abdominal pain
Joint pain or muscle discomfort
Serious Side Effects
Heart Problems: Changes in heart rhythm or reduced heart function in some patients
Liver Problems: Increased liver enzymes or signs of liver injury
Secondary Skin Cancers: Development of new skin lesions or other skin-related abnormalities
Patients should report any unusual symptoms to their doctor immediately.
Storage:
Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep the capsules in their original packaging and out of reach of children.
Frequently Asked Questions (FAQs)
1. Is Braftovi (Encorafenib) 75mg used alone or with other medicines?
Encorafenib is often used in combination with other anticancer medicines depending on the type of cancer being treated.
2. Why is mutation testing required before using Encorafenib?
Encorafenib works best in cancers with specific BRAF mutations, so genetic testing helps confirm whether the treatment is appropriate.
3. Is Braftovi (Encorafenib) 75mg chemotherapy?
No. Braftovi is not traditional chemotherapy. It is a targeted therapy that works by blocking abnormal cancer growth signals.
4. Can patients stop taking Encorafenib when they feel better?
No. Patients should continue treatment exactly as prescribed unless the oncologist advises otherwise.
5. Can pregnant women take Encoraf 75mg?
No. Encoraf 75mg must not be used during pregnancy because Encorafenib may harm the unborn baby.
6. Is Encoraf 75mg the same as Braftovi?
Encoraf 75mg contains Encorafenib, the same active ingredient found in Braftovi. Generic versions is available.
7. Do I need a prescription to buy Encoraf (Encorafenib) 75mg?
Yes. Encoraf 75mg is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
Medical Disclaimer
Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Braftovi (Encorafenib) is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.
